Research Article

Heart Rate Variability in HIV Patients, Diabetics, and Controls: The AGATAA Study

Table 3

Proportion of HIV-infected participants (treated or not treated with HAART) or diabetic patients with time and frequency domain indices of heart rate variability inside the limits or under or above the interquartile interval of the control group.

HAART 𝑁 = 2 9 NaΓ―ve 𝑁 = 2 8 Diabetics 𝑁 = 4 4
Time indexFrequency indexTime indexFrequency indexTime indexFrequency index

All index within the control interquartile range, 𝑛 (%)2 (7.1)11 (39.3)3 (10.7)11 (39.3)7 (16.7)16 (38.1)
All index below the control 25th percentile, 𝑛 (%)4 (14.3)β€”2 (7.1)β€”7 (16.7)β€”
One or more index exclusively below the control 25th percentile, 𝑛 (%)8 (28.5)3 (10.7)5 (17.9)5 (17.9)7 (16.7) 5 (11.9)
All index above the control 75th percentile, 𝑛 (%)4 (14.3)β€”4 (14.3)β€”1 (2.3)β€”
One or more index exclusively above the control 75th percentile, 𝑛 (%)5 (17.9)1 (3.6)9 (32.1)β€”10 (23.8)β€”
More than one index simultaneously below the control 25th percentile and above the control 75th percentile, 𝑛 (%)5 (17.9)13 (46.4)5 (17.9)12 (42.8)10 (23.8)21 (50)

HAART: highly active antiretroviral therapy.